Tefron Statistics
Total Valuation
Tefron has a market cap or net worth of ILS 275.94 million. The enterprise value is 293.98 million.
Market Cap | 275.94M |
Enterprise Value | 293.98M |
Important Dates
The last earnings date was Monday, August 18, 2025.
Earnings Date | Aug 18, 2025 |
Ex-Dividend Date | Apr 1, 2025 |
Share Statistics
Current Share Class | 12.70M |
Shares Outstanding | n/a |
Shares Change (YoY) | +1.08% |
Shares Change (QoQ) | -1.48% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 4.21M |
Valuation Ratios
The trailing PE ratio is 7.10.
PE Ratio | 7.10 |
Forward PE | n/a |
PS Ratio | 0.31 |
PB Ratio | 1.01 |
P/TBV Ratio | 1.10 |
P/FCF Ratio | 16.47 |
P/OCF Ratio | 4.60 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.59, with an EV/FCF ratio of 17.55.
EV / Earnings | 7.56 |
EV / Sales | 0.33 |
EV / EBITDA | 3.59 |
EV / EBIT | 5.12 |
EV / FCF | 17.55 |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.25.
Current Ratio | 1.63 |
Quick Ratio | 0.94 |
Debt / Equity | 0.25 |
Debt / EBITDA | 0.84 |
Debt / FCF | 4.09 |
Interest Coverage | 6.18 |
Financial Efficiency
Return on equity (ROE) is 15.27% and return on invested capital (ROIC) is 11.38%.
Return on Equity (ROE) | 15.27% |
Return on Assets (ROA) | 6.75% |
Return on Invested Capital (ROIC) | 11.38% |
Return on Capital Employed (ROCE) | 18.28% |
Revenue Per Employee | 456,222 |
Profits Per Employee | 19,665 |
Employee Count | 1,977 |
Asset Turnover | 1.70 |
Inventory Turnover | 4.28 |
Taxes
In the past 12 months, Tefron has paid 8.81 million in taxes.
Income Tax | 8.81M |
Effective Tax Rate | 18.48% |
Stock Price Statistics
The stock price has decreased by -19.66% in the last 52 weeks. The beta is 1.07, so Tefron's price volatility has been similar to the market average.
Beta (5Y) | 1.07 |
52-Week Price Change | -19.66% |
50-Day Moving Average | 2,108.66 |
200-Day Moving Average | 2,761.03 |
Relative Strength Index (RSI) | 70.35 |
Average Volume (20 Days) | 24,921 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, Tefron had revenue of ILS 901.95 million and earned 38.88 million in profits. Earnings per share was 2.89.
Revenue | 901.95M |
Gross Profit | 198.63M |
Operating Income | 57.28M |
Pretax Income | 47.69M |
Net Income | 38.88M |
EBITDA | 73.50M |
EBIT | 57.28M |
Earnings Per Share (EPS) | 2.89 |
Balance Sheet
The company has 25.31 million in cash and 68.59 million in debt, giving a net cash position of -43.29 million.
Cash & Cash Equivalents | 25.31M |
Total Debt | 68.59M |
Net Cash | -43.29M |
Net Cash Per Share | n/a |
Equity (Book Value) | 272.70M |
Book Value Per Share | 21.69 |
Working Capital | 146.72M |
Cash Flow
In the last 12 months, operating cash flow was 59.94 million and capital expenditures -43.18 million, giving a free cash flow of 16.76 million.
Operating Cash Flow | 59.94M |
Capital Expenditures | -43.18M |
Free Cash Flow | 16.76M |
FCF Per Share | n/a |
Margins
Gross margin is 22.02%, with operating and profit margins of 6.35% and 4.31%.
Gross Margin | 22.02% |
Operating Margin | 6.35% |
Pretax Margin | 5.29% |
Profit Margin | 4.31% |
EBITDA Margin | 8.15% |
EBIT Margin | 6.35% |
FCF Margin | 1.86% |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 0.03%.
Dividend Per Share | 0.60 |
Dividend Yield | 0.03% |
Dividend Growth (YoY) | 2.20% |
Years of Dividend Growth | n/a |
Payout Ratio | 20.58% |
Buyback Yield | -1.08% |
Shareholder Yield | -1.06% |
Earnings Yield | 14.09% |
FCF Yield | 6.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on January 22, 2009. It was a reverse split with a ratio of 0.1.
Last Split Date | Jan 22, 2009 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Tefron has an Altman Z-Score of 2.58 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.58 |
Piotroski F-Score | 5 |